The association of exocrine function with malignant transformation in surgically resected intraductal papillary mucinous neoplasms

The association of exocrine function with malignant transformation in surgically resected intraductal papillary mucinous neoplasms - Low pancreatic enzyme and atrophy in IPMN

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020140

Enrollment

146

Registered

2015-12-14

Start date

2015-12-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intraductal papillary mucinous neoplasm

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with IPMN diagnosed by MRCP or CT preoperatively

Exclusion criteria

Exclusion criteria: 1. Patients with pancreatic carcinoma concomitant with IPMN 2. Patients with the stenosis of main pancreatic duct due to mass formation of invasive IPMN

Design outcomes

Primary

Measure	Time frame
the association of serum pancreatic enzymes and malignant IPMN	—

Secondary

Measure	Time frame
1. the association of serum pancreatic enzymes with pancreatic atrophy and pancreatic stone on CT 2. the association of serum pancreatic enzymes with pathological examination (atrophy and inflammation) 3. the association of pathological examination (atrophy and inflammation) with malignant IPMN	—

Countries

Japan

Contacts

Public ContactYosuke Yagi

Kobe University Graduate School of Medicine Division of Gastroenterology, Department of Internal medicine

goatomc@med.kobe-u.ac.jp078-382-6305

Outcome results